Page last updated: 2024-11-06

isofenphos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID32872
CHEMBL ID1882342
CHEBI ID6009
SCHEMBL ID26546
MeSH IDM0107553

Synonyms (77)

Synonym
brn 2949615
40 sd
amaze
isopropyl salicylate o-ester with o-ethyl isopropylphosphoramidothioate
2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy) benzoic acid 1-methylethyl ester
sra 12869
isopropyl salicylate ester of o-ethyl isopropylphosphoramidothioate
bay-sra-12869
isofenphos [bsi:iso]
discus
2-(o-aethyl-n-isopropylamidothiophosphoryloxy)-benzosaeure-isopropylester [german]
pyrfon
caswell no. 447ab
epa pesticide chemical code 109401
einecs 246-814-1
isophenphos [iso-french]
2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy)benzoic acid 1-methylethyl ester
sra 128691
benzoic acid, 2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy)-, 1-methylethyl ester
le-mat
salicylic acid, isopropyl ester, o-ester with o-ethyl isopropylphosphoramidothioate
hsdb 6983
bay-92114
isopropyl o-(ethoxy(isopropylamino)phosphinothioyl)salicylate
isopropyl salicylate o-ester with o-ethylisopropylphosphoramidothioate
phosphoramidothioic acid, isopropyl-, o-ethyl o-(2-isopropoxycarbonylphenyl) ester
isopropyl o-(ethoxy-n-isopropylamino(thiophosphoryl))salicylate
ai3-27748
benzoic acid, 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]-, 1-methylethyl ester
isophenphos
25311-71-1
isofenphos
o-ethyl o-(2-isopropoxycarbonyl)phenyl isopropylphosphoramidothioate
isopropylsalicylate, o-ester with o-ethyl isopropylphosphoramidothioate
2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]benzoic acid 1-methylethyl ester
propan-2-yl 2-({ethoxy[(propan-2-yl)amino]phosphorothioyl}oxy)benzoate
CHEBI:6009 ,
oftanol
1-methylethyl 2-({ethoxy[(1-methylethyl)amino]phosphorothioyl}oxy)benzoate
isopropyl 2-{[ethoxy(isopropylamino)phosphorothioyl]oxy}benzoate
1-methylethyl-2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy) benzoate
NCGC00164274-01
propan-2-yl 2-[ethoxy-(propan-2-ylamino)phosphinothioyl]oxybenzoate
inchi=1/c15h24no4ps/c1-6-18-21(22,16-11(2)3)20-14-10-8-7-9-13(14)15(17)19-12(4)5/h7-12h,6h2,1-5h3,(h,16,22)
hoqadatxfboegg-uhfffaoysa-
dtxsid8032417 ,
dtxcid6012417
tox21_302219
NCGC00255226-01
cas-25311-71-1
0514maw53a ,
2-(o-aethyl-n-isopropylamidothiophosphoryloxy)-benzosaeure-isopropylester
unii-0514maw53a
103982-06-5
benzoic acid, 2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy)-, 1-methylethyl ester, (-)-
103982-07-6
benzoic acid, 2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy)-, 1-methylethyl ester, (+)-
isofenphos [mi]
1-methylethyl 2-((ethoxy((1-methylethyl)amino)phosphinothioyl)oxy)benzoate
isofenphos [iso]
isofenphos [hsdb]
(rs)-(o-ethyl o-2-isopropoxycarbonylphenyl isopropylphosphoramidothioate)
SCHEMBL26546
isopropyl 2-([ethoxy(isopropylamino)phosphorothioyl]oxy)benzoate #
amidocid
pryfon
CHEMBL1882342
propan-2-yl 2-({ethoxy[(propan-2-yl)amino]sulfanylidene-$l^{5}-phosphanyl}oxy)benzoate
isofenphos, analytical standard
isofenphos 100 microg/ml in cyclohexane
isofenphos 10 microg/ml in cyclohexane
1-methylethyl 2-[[ethoxy[(1-methylethyl)amino]phosphinothioyl]oxy]benzoate, 9ci
o-ethyl o-2-isopropoxycarbonylphenyl isopropylphosphoramidothioate
J-015927
isopropyl 2-(ethoxy(isopropylamino)phosphorothioyloxy)benzoate
Q15632850
isopropyl 2-((ethoxy(isopropylamino)phosphorothioyl)oxy)benzoate

Research Excerpts

Actions

ExcerptReferenceRelevance
"Isofenphos is known to cause delayed neuropathy."( Delayed neuropathy in pigs induced by isofenphos.
Johnson, MK; Lamont, MH; Norman, IM; Parker, RM; Patel, RK; Porter, S; Quick, MP; Shaw, IC, 1995
)
1.28

Dosage Studied

ExcerptRelevanceReference
"4 for the first dosing time (15 min)."( In vivo and in vitro percutaneous absorption and skin evaporation of isofenphos in man.
Knaak, J; Maibach, HI; Melendres, J; Sedik, L; Wang, R; Wester, RC, 1992
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
organothiophosphate insecticide
organic phosphonate
phosphonic esterA phosphonic acid derivative in which one or both OH groups have been esterified.
salicylatesAny salt or ester arising from reaction of the carboxy group of salicylic acid, or any ester resulting from the condensation of the phenolic hydroxy group of salicylic acid with an organic acid.
isopropyl esterAny carboxylic ester resulting from the formal condensation of a carboxylic acid with the hydroxy group of propan-2-ol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
pregnane X receptorRattus norvegicus (Norway rat)Potency12.58930.025127.9203501.1870AID651751
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency2.75363.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency20.51050.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency48.96620.173734.304761.8120AID1346859
SMAD family member 3Homo sapiens (human)Potency48.96620.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency43.27710.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency48.44210.000221.22318,912.5098AID1259243; AID1259247; AID743042; AID743054; AID743063
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency48.29170.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency15.35530.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency4.89660.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency53.14090.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency29.85930.000817.505159.3239AID1159527; AID1159531; AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency31.12950.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency2.65130.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency31.57250.000229.305416,493.5996AID1259244; AID1259248; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency43.64120.001024.504861.6448AID743215
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency54.94100.023723.228263.5986AID743222
aryl hydrocarbon receptorHomo sapiens (human)Potency28.35610.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency38.57080.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency68.58960.001628.015177.1139AID1259385
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency54.48270.000323.4451159.6830AID743065; AID743067
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.48270.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency30.63790.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency30.63790.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (34.38)18.7374
1990's12 (37.50)18.2507
2000's6 (18.75)29.6817
2010's1 (3.13)24.3611
2020's2 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.00 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index36.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.03%)5.53%
Reviews2 (6.06%)6.00%
Case Studies5 (15.15%)4.05%
Observational0 (0.00%)0.25%
Other25 (75.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]